Literature DB >> 28271342

A comparison of the localization of rectal carcinomas according to the general rules of the Japanese classification of colorectal carcinoma (JCCRC) and Western guidelines.

Akira Tanaka1, Sotaro Sadahiro2, Toshiyuki Suzuki2, Kazutake Okada2, Gota Saito2.   

Abstract

PURPOSE: The aim of this study was to compare the localization of rectal cancers as classified according to the general rules of the Japanese classification of colorectal carcinoma (JCCRC) and also according to the European Society for Medical Oncology (ESMO) and the National Comprehensive Cancer Network (NCCN) guidelines, which are based on rigid endoscopic measurements.
METHODS: The medical records of patients scheduled to receive curative surgery for histologically proven rectal adenocarcinoma during 2009-2015 were investigated (n = 230). Rigid proctoscopy was performed in patients with rectal cancer located in the upper (Ra) or lower (Rb) division using double-contrast barium enema.
RESULTS: The median values of height from the anal verge were 7.5 cm (range 2-12) and 3 cm (0-9.5) on rigid proctoscopy for cancers assigned as Ra and Rb, respectively. All 159 cancers at Ra or Rb were located within 12 cm from the anal verge by rigid proctoscopy, while only 79.7% of Ra or 82.1% of Rb cancers were located in the mid (5.1-10 cm) or low (≤5 cm) rectum, respectively.
CONCLUSION: Ra and Rb cancers are deemed to be rectal cancers according to NCCN guidelines, but these classifications are not interchangeable with mid- and low-rectal cancers, respectively, according to the ESMO guidelines.

Entities:  

Keywords:  Discrepancy between Japan and Western countries; Guidelines for classification; Location of rectal cancer

Mesh:

Year:  2017        PMID: 28271342     DOI: 10.1007/s00595-017-1487-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

Review 1.  Double-contrast barium enema examination technique.

Authors:  S E Rubesin; M S Levine; I Laufer; H Herlinger
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Accuracy of digital rectal examination in the estimation of height of rectal lesions.

Authors:  V Thumbe; M Iqbal; S Bhalerao
Journal:  Tech Coloproctol       Date:  2007-05-25       Impact factor: 3.781

4.  Determination of the peritoneal reflection using intraoperative proctoscopy.

Authors:  Melissa M Najarian; G Eric Belzer; Thomas H Cogbill; Michelle A Mathiason
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

Review 5.  Transanal total mesorectal excision for rectal cancer.

Authors:  Suguru Hasegawa; Ryo Takahashi; Koya Hida; Kenji Kawada; Yoshiharu Sakai
Journal:  Surg Today       Date:  2015-06-09       Impact factor: 2.549

6.  Critical evaluation of the scientific content in clinical practice guidelines.

Authors:  Zaid M Abdelsattar; Bradley N Reames; Scott E Regenbogen; Samantha Hendren; Sandra L Wong
Journal:  Cancer       Date:  2014-11-06       Impact factor: 6.860

7.  The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.

Authors:  Suk-Hawn Lee; Enrique Hernandez de Anda; Charles O Finne; Robert D Madoff; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2005-12       Impact factor: 4.585

8.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

Authors:  Laurence Collette; Jean-Francois Bosset; Marcel den Dulk; France Nguyen; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Marianne Piérart; Gilles Calais
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

9.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

Review 10.  When is local excision appropriate for "early" rectal cancer?

Authors:  Kotaro Maeda; Yoshikazu Koide; Hidetoshi Katsuno
Journal:  Surg Today       Date:  2013-11-21       Impact factor: 2.549

View more
  2 in total

1.  Preoperative FOLFOX in resectable locally advanced rectal cancer can be a safe and promising strategy: the R-NAC-01 study.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tohru Funakoshi; Masahiro Hattori; Masanori Sato; You Kamiizumi; Kazuyoshi Omori; Masaru Nomura; Ryoichi Yokota; Masahiko Koike; Hirofumi Kon; Keisa Takeda; Hiroyuki Ishizu; Kunihiro Hirose; Daisuke Kuraya; Takahisa Ishikawa; Ryohei Murata; Hiroaki Iijima; Futoshi Kawamata; Tadashi Yoshida; Yosuke Ohno; Nozomi Minagawa; Norihiko Takahashi; Akinobu Taketomi
Journal:  Surg Today       Date:  2019-03-05       Impact factor: 2.549

2.  Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma.

Authors:  Sandra F Martins; Vânia Mariano; Mesquita Rodrigues; Adhemar Longatto-Filho
Journal:  Infect Agent Cancer       Date:  2020-03-05       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.